• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[益生菌布拉酵母菌对接受阿莫西林治疗的成年门诊患者预防抗生素相关性腹泻的作用]

[Effect of probiotic Saccharomyces boulardii on prevention of antibiotic-associated diarrhea in adult outpatients with amoxicillin treatment].

作者信息

Bravo María Verónica, Bunout Daniel, Leiva Laura, de la Maza María Pía, Barrera Gladys, de la Maza Javier, Hirsch Sandra

机构信息

Instituto de Nutrición y Tecnología de los Alimentos, Universidad de Chile, Santiago, Chile.

出版信息

Rev Med Chil. 2008 Aug;136(8):981-8. Epub 2008 Oct 7.

PMID:18949181
Abstract

BACKGROUND

Antibiotic-associated diarrhea is one of the most common adverse effects of antimicrobials. Any antimicrobial can potentially produce diarrhea but beta-lactamics have a higher risk. Among these, amoxicillin is widely indicated in ambulatory practice. One of the alternatives suggested to prevent antibiotic-associated diarrhea, is the use of the probiotic Saccharomyces boulardii.

AIM

To evaluate whether the concomitant use of Saccharomyces boulardii and amoxicillin can prevent antibiotic associated diarrhea in ambulatory adults with acute infections diseases, without provoking other adverse effects.

MATERIAL AND METHODS

Eighty six adults (aged 15 to 81 years) with acute infectious diseases, excluding those arising in the gastrointestinal tract, that received a prescription of oral amoxicillin for 5 to 10 days, were included. In a controlled randomized, double blind trial, 41 patients were assigned to receive lyophilized Saccharomyces boulardii (500 mg/day) during 12 days, and 45 patients were assigned to placebo for the same period.

RESULTS

Ten percent of patients (9/86) reported acute diarrhea, 9,8% (4/41) in the experimental group and 11.196 (5/45) in the control group (p = 100). No adverse effects were associated to the use of the probiotic.

CONCLUSIONS

Saccharomyces boulardii (500 mg/day) did not prevent diarrhea related to amoxicillin.

摘要

背景

抗生素相关性腹泻是抗菌药物最常见的不良反应之一。任何抗菌药物都有可能导致腹泻,但β-内酰胺类药物的风险更高。其中,阿莫西林在门诊治疗中应用广泛。预防抗生素相关性腹泻的一种建议方法是使用益生菌布拉酵母菌。

目的

评估布拉酵母菌与阿莫西林联合使用能否预防患有急性感染性疾病的门诊成年患者发生抗生素相关性腹泻,且不引发其他不良反应。

材料与方法

纳入86名患有急性感染性疾病(不包括胃肠道疾病)的成年人(年龄15至81岁),他们接受了为期5至10天的口服阿莫西林治疗。在一项对照随机双盲试验中,41名患者被分配在12天内每日服用冻干布拉酵母菌(500毫克),45名患者在同一时期服用安慰剂。

结果

10%的患者(9/86)报告出现急性腹泻,试验组为9.8%(4/41),对照组为11.1%(5/45)(p = 1.00)。使用益生菌未出现相关不良反应。

结论

每日服用500毫克布拉酵母菌不能预防与阿莫西林相关的腹泻。

相似文献

1
[Effect of probiotic Saccharomyces boulardii on prevention of antibiotic-associated diarrhea in adult outpatients with amoxicillin treatment].[益生菌布拉酵母菌对接受阿莫西林治疗的成年门诊患者预防抗生素相关性腹泻的作用]
Rev Med Chil. 2008 Aug;136(8):981-8. Epub 2008 Oct 7.
2
Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial.布拉酵母菌预防儿童抗生素相关性腹泻:一项随机双盲安慰剂对照试验
Aliment Pharmacol Ther. 2005 Mar 1;21(5):583-90. doi: 10.1111/j.1365-2036.2005.02356.x.
3
Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.布拉氏酵母菌在14天三联抗幽门螺杆菌治疗中的疗效与安全性:一项前瞻性随机安慰剂对照双盲研究。
Helicobacter. 2007 Aug;12(4):309-16. doi: 10.1111/j.1523-5378.2007.00516.x.
4
Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study.预防性使用布拉酵母菌预防抗生素相关性腹泻:一项前瞻性研究。
Med Sci Monit. 2006 Apr;12(4):PI19-22. Epub 2006 Mar 28.
5
Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo.与安慰剂相比,布拉氏酵母菌预防β-内酰胺类抗生素相关性腹泻的效果
Am J Gastroenterol. 1995 Mar;90(3):439-48.
6
Review article: yeast as probiotics -- Saccharomyces boulardii.综述文章:作为益生菌的酵母——布拉氏酵母菌。
Aliment Pharmacol Ther. 2007 Sep 15;26(6):767-78. doi: 10.1111/j.1365-2036.2007.03442.x.
7
Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial.布拉氏酵母菌散剂预防成年住院患者抗生素相关性腹泻的随机、双盲、安慰剂对照、单中心临床研究
Am J Gastroenterol. 2012 Jun;107(6):922-31. doi: 10.1038/ajg.2012.56. Epub 2012 Apr 3.
8
Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebo-controlled study.布拉氏酵母菌治疗儿童急性腹泻:一项随机、安慰剂对照研究。
Acta Paediatr. 2007 Apr;96(4):538-41. doi: 10.1111/j.1651-2227.2007.00191.x. Epub 2007 Feb 14.
9
Unraveling the causes of negative studies: a case of S boulardii for the prevention of antibiotic-associated diarrhea.剖析阴性研究的原因:以布拉酵母菌预防抗生素相关性腹泻为例。
Rev Med Chil. 2009 May;137(5):719-20. Epub 2009 Jul 17.
10
[Saccharomyces boulardii modulates dendritic cell properties and intestinal microbiota disruption after antibiotic treatment].[布拉氏酵母菌对抗生素治疗后树突状细胞特性及肠道微生物群紊乱的调节作用]
Gastroenterol Clin Biol. 2010 Sep;34 Suppl 1:S71-8. doi: 10.1016/S0399-8320(10)70024-5.

引用本文的文献

1
Probiotics for the prevention of antibiotic-associated diarrhoea: a systematic review and meta-analysis.益生菌预防抗生素相关性腹泻的系统评价和荟萃分析。
BMJ Open. 2021 Aug 12;11(8):e043054. doi: 10.1136/bmjopen-2020-043054.
2
Probiotics for the Prevention of Antibiotic-associated Diarrhea in Adults: A Meta-Analysis of Randomized Placebo-Controlled Trials.益生菌预防成人抗生素相关性腹泻:随机安慰剂对照试验的荟萃分析。
J Clin Gastroenterol. 2021 Jul 1;55(6):469-480. doi: 10.1097/MCG.0000000000001464.
3
AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders.
美国胃肠病学会关于益生菌在胃肠道疾病管理中作用的技术审查。
Gastroenterology. 2020 Aug;159(2):708-738.e4. doi: 10.1053/j.gastro.2020.05.060. Epub 2020 Jun 9.
4
Probiotics in the next-generation sequencing era.下一代测序时代的益生菌。
Gut Microbes. 2020;11(1):77-93. doi: 10.1080/19490976.2019.1586039. Epub 2019 Apr 5.
5
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.用于预防成人和儿童艰难梭菌相关性腹泻的益生菌
Cochrane Database Syst Rev. 2017 Dec 19;12(12):CD006095. doi: 10.1002/14651858.CD006095.pub4.
6
Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review.益生菌用于预防艰难梭菌感染的一级和二级预防:一项荟萃分析和系统评价。
Antibiotics (Basel). 2015 Apr 13;4(2):160-78. doi: 10.3390/antibiotics4020160.
7
Antimicrobial and probiotic properties of yeasts: from fundamental to novel applications.酵母的抗菌和益生菌特性:从基础到新颖的应用。
Front Microbiol. 2012 Dec 19;3:421. doi: 10.3389/fmicb.2012.00421. eCollection 2012.
8
Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.布拉氏酵母菌散剂治疗成人患者的系统评价和荟萃分析。
World J Gastroenterol. 2010 May 14;16(18):2202-22. doi: 10.3748/wjg.v16.i18.2202.